BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 24951318)

  • 1. Serum reactive oxygen species modulator 1 (Romo1) as a potential diagnostic biomarker for non-small cell lung cancer.
    Lee SH; Lee JS; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH
    Lung Cancer; 2014 Aug; 85(2):175-81. PubMed ID: 24951318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive oxygen species modulator 1 (Romo1) overexpression is an independent predictor of poor survival in NSCLC patients who undergo surgical resection.
    Lee SH; Min JW; Lee JS; Kim CH; Yoo YD; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH
    Lung Cancer; 2015 Jan; 87(1):45-52. PubMed ID: 25468147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive Oxygen Species Modulator 1 (Romo1) Predicts Poor Outcomes in Advanced Non-small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy.
    Lee SH; Choi SI; Lee JS; Kim CH; Jung WJ; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH
    Cancer Res Treat; 2017 Jan; 49(1):141-149. PubMed ID: 27188201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive oxygen species modulator 1 (Romo1) as a novel diagnostic marker for lung cancer-related malignant effusion.
    Lee SH; Park MJ; Choi SI; Lee EJ; Lee SY; In KH
    Medicine (Baltimore); 2017 Jan; 96(4):e5975. PubMed ID: 28121949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
    Fan J; Yu H; Lv Y; Yin L
    Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis.
    Cui C; Sun X; Zhang J; Han D; Gu J
    J Cancer Res Ther; 2014 Nov; 10 Suppl():C131-4. PubMed ID: 25450270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of combined detection of reactive oxygen species modulator 1 and adenosine deaminase in pleural effusion in the identification of NSCLC associated malignant pleural effusion.
    Zhang F; Wang J; Fu J; Hu L; Zheng X; Wang Y; Chen B
    J Clin Lab Anal; 2020 Mar; 34(3):e23091. PubMed ID: 31709646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cyfra21-1 as a biomarker in patients with nonsmall cell lung cancer.
    Zhao H; Shi X; Liu J; Chen Z; Wang G
    J Cancer Res Ther; 2014 Nov; 10 Suppl():C215-7. PubMed ID: 25450285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum miR-499 as a novel diagnostic and prognostic biomarker in non-small cell lung cancer.
    Li M; Zhang Q; Wu L; Jia C; Shi F; Li S; Peng A; Zhang G; Song X; Wang C
    Oncol Rep; 2014 Apr; 31(4):1961-7. PubMed ID: 24549225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum lemur tyrosine kinase-3: a novel biomarker for screening primary non-small cell lung cancer and predicting cancer progression.
    Zhang K; Chen L; Deng H; Zou Y; Liu J; Shi H; Xu B; Lu M; Li C; Jiang J; Wang Z
    Int J Clin Exp Pathol; 2015; 8(1):629-35. PubMed ID: 25755755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Romo1 promotes production of reactive oxygen species and invasiveness of hepatic tumor cells.
    Chung JS; Park S; Park SH; Park ER; Cha PH; Kim BY; Chung YM; Woo SR; Han CJ; Kim SB; Suh KS; Jang JJ; Lee K; Choi DW; Lee S; Lee GY; Hahm KB; Shin JA; Kim BS; Noh KH; Kim TW; Lee KH; Yoo YD
    Gastroenterology; 2012 Oct; 143(4):1084-94.e7. PubMed ID: 22749933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the clinical significance of serum HE4 levels in lung cancer and pulmonary tuberculosis.
    Liu W; Yang J; Chi PD; Zheng X; Dai SQ; Chen H; Xu BL; Liu WL
    Int J Tuberc Lung Dis; 2013 Oct; 17(10):1346-53. PubMed ID: 24025389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum endothelial monocyte-activating polypeptide-II: a novel biomarker in patients with non-small-cell lung cancer.
    Sen E; Ulger F; Kaya A; Akar N; Gonullu U
    Clin Lung Cancer; 2008 May; 9(3):166-70. PubMed ID: 18621627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of serum MET in non-small-cell lung cancer and its clinical significance.
    Li D; Li F; Wu Y; Zhou D; Chen H
    Clin Biochem; 2015 Feb; 48(3):110-4. PubMed ID: 25489726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of urinary and serum cross-linked N-telopeptide of type I collagen (NTx) for diagnosis of bone metastasis in patients with lung cancer.
    Tamiya M; Tokunaga S; Okada H; Suzuki H; Kobayashi M; Sasada S; Okamoto N; Morishita N; Matsuura Y; Miyamoto N; Hattori M; Taira K; Daga H; Takeda K; Hirashima T
    Clin Lung Cancer; 2013 Jul; 14(4):364-9. PubMed ID: 23276824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum biomarkers facilitate the recognition of early- stage cancer and may guide the selection of surgical candidates: a study of carcinoembryonic antigen and tissue polypeptide antigen in patients with operable non-small cell lung cancer.
    Buccheri G; Ferrigno D
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):891-9. PubMed ID: 11689793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients.
    Köhler J; Schuler M; Gauler TC; Nöpel-Dünnebacke S; Ahrens M; Hoffmann AC; Kasper S; Nensa F; Gomez B; Hahnemann M; Breitenbuecher F; Cheufou D; Özkan F; Darwiche K; Hoiczyk M; Reis H; Welter S; Eberhardt WE; Eisenacher M; Teschler H; Stamatis G; Schmiegel W; Hahn SA; Baraniskin A
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):795-805. PubMed ID: 26687686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum interleukin-17 as a diagnostic and prognostic marker for non-small cell lung cancer.
    Xu C; Hao K; Yu L; Zhang X
    Biomarkers; 2014 Jun; 19(4):287-90. PubMed ID: 24731052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis value of serum B7-H3 expression in non-small cell lung cancer.
    Zhang G; Xu Y; Lu X; Huang H; Zhou Y; Lu B; Zhang X
    Lung Cancer; 2009 Nov; 66(2):245-9. PubMed ID: 19269710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of serum bone sialoprotein in patients with bone metastasis of non-small cell lung cancer.
    He JJ; Zhi K; Liu GF
    Onkologie; 2011; 34(11):584-8. PubMed ID: 22104154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.